Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #27 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 4 Oct 2021 | Shaik Khaleel | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Manikandan Ramalingam | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Maddargi Devendra Kumar | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Guntamukkala Sivaram Prasad | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Atul Dhavle | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Murali Mohana Raju Gottumukkala | Employee / designated person | Buy | 0 | ₹0 |
| 4 Oct 2021 | Chaitanya Tummala | Key managerial personnel | Buy | 0 | ₹0 |
| 4 Oct 2021 | Jaiashokan Velusamy | Employee / designated person | Buy | 0 | ₹0 |
| 4 Aug 2021 | Umesh Kumar Gupta | Employee / designated person | Sell | 0 | ₹0 |
| 4 Aug 2021 | Suryanarayana Murthy Ponnada | Employee / designated person | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 11 Sep 2026 | SUNDARAM MUTUAL FUND | Block | Buy | 573,065 | 872.5000 | NSE |
| 11 Sep 2026 | SMALLCAP WORLD FUND INC | Block | Buy | 3,474,080 | 872.5000 | NSE |
| 11 Sep 2026 | SBI LIFE INSURANCE COMPANY LIMITED | Block | Buy | 573,065 | 872.5000 | NSE |
| 11 Sep 2026 | OPTIMIX WHOLESALE GLOBAL EMERGING MARKETS SHARE TRUST | Block | Buy | 182,350 | 872.5000 | NSE |
| 11 Sep 2026 | MYRAA VARUN RAHEJA | Block | Buy | 687,679 | 872.5000 | NSE |
| 11 Sep 2026 | KRISHNA PRASAD CHIGURUPATI | Block | Sell | 13,295,129 | 872.5000 | NSE |
| 11 Sep 2026 | KOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED | Block | Buy | 1,154,316 | 872.5000 | NSE |
| 11 Sep 2026 | JAGDISH NARESH MASTER | Block | Buy | 300,000 | 872.5000 | NSE |
| 11 Sep 2026 | GOLDMAN SACHS BANK EUROPE SE | Block | Buy | 1,173,916 | 872.5000 | NSE |
| 11 Sep 2026 | FLORIDA RETIREMENT SYSTEM | Block | Buy | 416,692 | 872.5000 | NSE |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 21 Jul 2026 | Financial Results | Yes |
| 29 Apr 2026 | Financial Results/Dividend | Yes |
| 23 Jan 2026 | Financial Results | Yes |
| 23 Dec 2025 | Fund Raising | — |
| 13 Nov 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 29 Sep 2026 | Company Update | Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 25 Sep 2026 | Insider Trading / SAST | Granules India Ltd-$ - 532482 - Closure of Trading Window |
| 25 Sep 2026 | Insider Trading / SAST | Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 16 Sep 2026 | Company Update | Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Allotment |
| 15 Sep 2026 | Company Update | Granules India Ltd-$ - 532482 - Update |
| 12 Sep 2026 | Insider Trading / SAST | Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 11 Sep 2026 | Company Update | Granules India Ltd-$ - 532482 - Update |
| 11 Sep 2026 | Company Update | Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.